Antiretroviral agents should be dose adjusted in renal and hepatic impairment.
Edmunds-Ogbuokiri
J
J
Xavier University of Louisiana College of Pharmacy, Medical Center of Louisiana at New Orleans, USA.
D004305:Dose-Response Relationship, Drug; D015658:HIV Infections / Q000188:drug therapy* / Q000503:physiopathology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D008099:Liver / Q000503:physiopathology*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors